close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pro-Dex, Inc. - Common Stock (NQ:PDEX)

26.22 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pro-Dex, Inc. - Common Stock

< Previous 1 2 Next >
Pro-Dex, Inc. Announces Clarification Related to Trading Symbol
Via ACCESS Newswire
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Is PRO-DEX INC (NASDAQ:PDEX) suited for growth investing?
A fundamental analysis of (NASDAQ:PDEX): Why PRO-DEX INC (NASDAQ:PDEX) qualifies as a high growth stock. 
Via Chartmill
PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why.
A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) showing high EPS and FCF growth while beating expectations 
Via Chartmill
Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results
Via ACCESSWIRE
Pro-Dex Revenue Jumps 16% in Fiscal Q4
Via The Motley Fool
Pro-Dex, Inc. Announces Fiscal 2025 Fourth Quarter and Full-Year Results
Via ACCESS Newswire
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Pro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month Results
Via ACCESS Newswire
Pro-Dex Inc (NASDAQ:PDEX): A Strong Candidate for Little Book Investors
Pro-Dex Inc (NASDAQ:PDEX): A Strong Candidate for Little Book Investors 
Via Chartmill
Evaluating PRO-DEX INC (NASDAQ:PDEX) for Growth Investment Opportunities.
A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why. 
Via Chartmill
Is PRO-DEX INC (NASDAQ:PDEX) suited for growth investing?
A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why. 
Via Chartmill
Pro-Dex, Inc. Announces Fiscal 2025 Second Quarter and Six-Month Results
Via ACCESS Newswire
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results
Via ACCESSWIRE
Starbucks To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Monday
 
Via Benzinga
PDEX Stock Earnings: Pro-Dex Misses EPS, Beats Revenue for Q3 2024
PDEX stock results show that Pro-Dex missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Pro-Dex, Inc. Announces Fiscal 2024 Third Quarter And Nine-Month Results
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results
Via ACCESSWIRE
3 Very Undervalued Stocks With Strong Growth Prospects
Although the equities sector saw some impressive gains this year, there’s still time for undervalued stocks with strong growth potential. 
Via InvestorPlace
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
Via ACCESSWIRE
Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast
Via ACCESSWIRE
Pro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year Results
Via ACCESSWIRE
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today